JP2022543658A5 - - Google Patents

Info

Publication number
JP2022543658A5
JP2022543658A5 JP2022507630A JP2022507630A JP2022543658A5 JP 2022543658 A5 JP2022543658 A5 JP 2022543658A5 JP 2022507630 A JP2022507630 A JP 2022507630A JP 2022507630 A JP2022507630 A JP 2022507630A JP 2022543658 A5 JP2022543658 A5 JP 2022543658A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
sequence shown
acid sequence
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022507630A
Other languages
English (en)
Japanese (ja)
Other versions
JP7802651B2 (ja
JP2022543658A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/045511 external-priority patent/WO2021026508A1/en
Publication of JP2022543658A publication Critical patent/JP2022543658A/ja
Publication of JP2022543658A5 publication Critical patent/JP2022543658A5/ja
Priority to JP2025139120A priority Critical patent/JP2025176044A/ja
Application granted granted Critical
Publication of JP7802651B2 publication Critical patent/JP7802651B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022507630A 2019-08-07 2020-08-07 抗nampt抗体及びその用途 Active JP7802651B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025139120A JP2025176044A (ja) 2019-08-07 2025-08-22 抗nampt抗体及びその用途

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962883952P 2019-08-07 2019-08-07
US62/883,952 2019-08-07
PCT/US2020/045511 WO2021026508A1 (en) 2019-08-07 2020-08-07 Anti-nampt antibodies and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025139120A Division JP2025176044A (ja) 2019-08-07 2025-08-22 抗nampt抗体及びその用途

Publications (3)

Publication Number Publication Date
JP2022543658A JP2022543658A (ja) 2022-10-13
JP2022543658A5 true JP2022543658A5 (cg-RX-API-DMAC7.html) 2023-08-16
JP7802651B2 JP7802651B2 (ja) 2026-01-20

Family

ID=74503750

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022507630A Active JP7802651B2 (ja) 2019-08-07 2020-08-07 抗nampt抗体及びその用途
JP2025139120A Pending JP2025176044A (ja) 2019-08-07 2025-08-22 抗nampt抗体及びその用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025139120A Pending JP2025176044A (ja) 2019-08-07 2025-08-22 抗nampt抗体及びその用途

Country Status (7)

Country Link
US (3) US11142586B2 (cg-RX-API-DMAC7.html)
EP (1) EP4010368A4 (cg-RX-API-DMAC7.html)
JP (2) JP7802651B2 (cg-RX-API-DMAC7.html)
CN (1) CN114929738B (cg-RX-API-DMAC7.html)
AU (1) AU2020325315A1 (cg-RX-API-DMAC7.html)
CA (1) CA3147020A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021026508A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111201030B (zh) 2017-07-25 2024-11-01 真和制药有限公司 通过阻断tim-3和其配体的相互作用治疗癌症
CN113614535B (zh) 2018-10-31 2024-08-16 亚利桑那大学评议会 用于辐射诱导的肺损伤的生物标志物和使用方法
KR20210124308A (ko) 2019-01-30 2021-10-14 트루바인딩 아이엔씨. 항-gal3 항체 및 이의 용도
CN114929738B (zh) * 2019-08-07 2026-01-02 水肺治疗公司 抗nampt抗体及其用途
US11129878B1 (en) * 2020-03-24 2021-09-28 Ampio Pharmaceuticals, Inc. Methods for treating diseases associated with respiratory viruses
MX2022014786A (es) 2020-05-26 2023-01-16 Truebinding Inc Metodos para tratar enfermedades inflamatorias mediante el bloqueo de galectina-3.
CN117815243B (zh) * 2023-12-29 2025-01-24 四川大学华西医院 一种化合物在制备治疗肝纤维化的药物以及nampt抑制剂中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2480059C (en) 2002-03-22 2015-11-24 Amrad Operations Pty. Ltd. Monoclonal antibody against interleukin-13 receptor alpha 1 (il-13r.alpha.1)
AU2003285540A1 (en) 2002-11-29 2004-06-23 Rsr Limited Antibody for the thyrotropin receptor and uses thereof
PE20091163A1 (es) 2007-11-01 2009-08-09 Wyeth Corp Anticuerpos para gdf8
US9409983B2 (en) * 2009-07-23 2016-08-09 The Board Of Trustess Of The University Of Illinois Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseases
EP2852585A1 (en) * 2012-05-11 2015-04-01 AbbVie Inc. Nampt inhibitors
WO2016090337A1 (en) * 2014-12-05 2016-06-09 Memorial Sloan-Kettering Cancer Center Chimeric antigen receptors targeting fc receptor-like 5 and uses thereof
HRP20240357T1 (hr) 2014-12-24 2024-06-07 Autolus Limited Stanica
US10526410B2 (en) * 2015-04-15 2020-01-07 Anaptysbio, Inc. Antibodies directed against interleukin 36 receptor (IL-36R)
CN105055412B (zh) * 2015-08-20 2018-06-19 四川大学 Nampt抑制剂在制备治疗可卡因成瘾的药物中的用途
WO2017041114A2 (en) * 2015-09-03 2017-03-09 The Children's Mercy Hospital Anti-nicotinamide phosphoribosyltransferase antibody genes and methods of use thereof
EP3610018B1 (en) * 2017-04-14 2023-06-07 Arizona Board of Regents on Behalf of the University of Arizona Compositions and methods for treating pulmonary fibrosis
CN111886246B (zh) * 2017-12-29 2024-12-17 艾莱克特有限责任公司 抗tmem106b抗体及其使用方法
CN114929738B (zh) * 2019-08-07 2026-01-02 水肺治疗公司 抗nampt抗体及其用途

Similar Documents

Publication Publication Date Title
JP2024150751A5 (cg-RX-API-DMAC7.html)
KR102757960B1 (ko) 간세포암(hepatocellular carcinoma: HCC)에 대한 면역 치료
JP2023123726A5 (cg-RX-API-DMAC7.html)
JP2019527194A5 (cg-RX-API-DMAC7.html)
US20050288491A1 (en) Super-humanized antibodies against respiratory syncytial virus
JP2023515223A5 (cg-RX-API-DMAC7.html)
JP2020514277A5 (cg-RX-API-DMAC7.html)
JP2018535650A5 (cg-RX-API-DMAC7.html)
JP2018505177A5 (cg-RX-API-DMAC7.html)
JP2021514973A5 (cg-RX-API-DMAC7.html)
RU2017102514A (ru) Гуманизированные анти-тау-антитела
JP2019522961A5 (cg-RX-API-DMAC7.html)
JP2014500009A5 (cg-RX-API-DMAC7.html)
JP2019505527A5 (cg-RX-API-DMAC7.html)
JP2011207882A5 (cg-RX-API-DMAC7.html)
JP2003528052A5 (cg-RX-API-DMAC7.html)
JP2017507652A5 (cg-RX-API-DMAC7.html)
JP2014527814A5 (cg-RX-API-DMAC7.html)
JP2013502913A5 (cg-RX-API-DMAC7.html)
RU2018129874A (ru) Антитела против фактора свертывания xi
JP2018506277A5 (cg-RX-API-DMAC7.html)
JP2024042072A5 (cg-RX-API-DMAC7.html)
JP2024016024A5 (cg-RX-API-DMAC7.html)
JP2021511387A5 (cg-RX-API-DMAC7.html)
JP2024541680A5 (cg-RX-API-DMAC7.html)